# Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer

> **NCT02872779** · NA · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 74 (actual)

## Conditions studied

- Circulating Markers
- Metastatic Colorectal Cancer

## Interventions

- **PROCEDURE:** Blood sampling for free mutant DNA analysis

## Key facts

- **NCT ID:** NCT02872779
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-18
- **Primary completion:** 2020-08-10
- **Final completion:** 2020-08-10
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02872779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02872779, "Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02872779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*